A Glycosylated Recombinant Human Granulocyte Colony Stimulating Factor Produced in a Novel Protein Production System (AVI-014) in Healthy Subjects: A First-In Human, Single Dose, Controlled Study

BMC Clinical Pharmacology
doi 10.1186/1472-6904-9-2
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Springer Science and Business Media LLC

Related search

Pharmacokinetics of Glycosylated Recombinant Human Granulocyte Colony-Stimulating Factor (Lenograstim) in Healthy Male Volunteers

British Journal of Clinical Pharmacology
Pharmacology
1999English

Human Recombinant Granulocyte-Macrophage Colony-Stimulating Factor: A Multilineage Hematopoietin

Science
MultidisciplinaryPhilosophy of ScienceHistory
1985English

Effects of Recombinant Granulocyte Colony-Stimulating Factor and Granulocyte-Macrophage Colony-Stimulating Factor on Platelet Aggregation in Healthy Volunteers

Turkiye Klinikleri Journal of Medical Sciences
Medicine
2015English

Low-Resolution Structure of Recombinant Human Granulocyte-Macrophage Colony Stimulating Factor

Journal of Molecular Biology
Structural BiologyMolecular BiologyBiophysics
1991English

Safety of Recombinant Human Granulocyte-Macrophage Colony-Stimulating Factor in Healing Pediatric Severe Burns

Genetics and Molecular Research
MedicineGeneticsMolecular Biology
2015English

Treatment With Molgramostim (Recombinant Human Granulocyte-Macrophage Colony Stimulating Factor, Rhugm-Csf, Mielogen) and Lenograstim (Granulocyte-Colony Stimulating Factor) Improves Experimental Colitis in Rats

BioMed Research International
ImmunologyMolecular BiologyBiochemistryMicrobiology MedicineGenetics
2019English

Neuroprotective Effect of Recombinant Human Granulocyte Colony-Stimulating Factor in Transient Focal Ischemia of Mice

Journal of Cerebral Blood Flow and Metabolism
NeurologyCardiovascular MedicineCardiology
2005English

Use of Recombinant Human Granulocyte-Macrophage Colony Stimulating Factor in an Infant With Reticular Dysgenesis

European Journal of Pediatrics
Child HealthPediatricsPerinatology
1994English

Clinical Efficacy and Safety of Tevagrastim® (XM02), a Biosimilar Recombinant Human Granulocyte Colony-Stimulating Factor

Biosimilars
2013English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy